Ihor R. Lemischka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ihor R. Lemischka has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Craig T. Jordan
Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO
3 shared publications - Kateri A. Moore
Department of Molecular Biology, Princeton University, Lewis Thomas Laboratory, Princeton, NJ 08544, USA
3 shared publications C M Astle
2 shared publicationsD E Harrison
2 shared publicationsMoshe Pritsker
2 shared publicationsA.Elena Searles
1 shared publication
Latest Publications
- 2 May 2006
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (18) , 6946-6951
Genomewide gain-of-function genetic screen identifies functionally active genes in mouse embryonic stem cells
Embryonic stem (ES) cells hold great promise for the future of medicine. To elucidate the molecular mechanisms that control ES cell self-renewal and differentiation, a comprehensive knowledge of the molecules involved in these processes is required. Here we describe an effective approach for genomewide identification of functionally active genes in ES cells. This approach combines genetic screens based on cDNA libraries with microarray detection methods to permit high-throughput functional analyses. We implement this strategy to identify genes whose overexpression can maintain phenotypic properties of undifferentiated mouse ES cells under differentiation-inducing conditions, specifically in the absence of leukemia inhibitory factor. The identified genes encode a variety of regulatory proteins whose function in ES cells was previously unknown. Moreover, our approach is capable of detecting genes whose overexpression promote differentiation or cell death. Overall, our studies establish a methodology for highly sensitive identification of genes that confer particular phenotypes on ES cells.
- 2 May 2006
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (18) , 6946-6951
Genomewide gain-of-function genetic screen identifies functionally active genes in mouse embryonic stem cells
Embryonic stem (ES) cells hold great promise for the future of medicine. To elucidate the molecular mechanisms that control ES cell self-renewal and differentiation, a comprehensive knowledge of the molecules involved in these processes is required. Here we describe an effective approach for genomewide identification of functionally active genes in ES cells. This approach combines genetic screens based on cDNA libraries with microarray detection methods to permit high-throughput functional analyses. We implement this strategy to identify genes whose overexpression can maintain phenotypic properties of undifferentiated mouse ES cells under differentiation-inducing conditions, specifically in the absence of leukemia inhibitory factor. The identified genes encode a variety of regulatory proteins whose function in ES cells was previously unknown. Moreover, our approach is capable of detecting genes whose overexpression promote differentiation or cell death. Overall, our studies establish a methodology for highly sensitive identification of genes that confer particular phenotypes on ES cells.
- 12 January 2006
- Published by Taylor & Francis in Cell Cycle
- Vol. 5 (4) , 347-351
Alternative Splicing Increases Complexity of Stem Cell Transcriptome
Development of highly anticipated stem cell-based therapies requires a detailed understanding of mechanisms regulating biological properties of these cells. Comprehensive identification of all biological molecules produced in stem cells is an important step toward this goal. During the past several years, microarray studies have essentially identified genes that are transcriptionally activated in various embryonic and adult stem cell populations. However, the extent of post-transcriptional modifications within the stem cell transcriptome remained undetermined. Recently, we presented evidence that thousands of genes expressed in hematopoietic and embryonic stem cells undergo alternative splicing. Using combined computational and experimental analyses, we found that the frequency of alternative splicing is especially high in tissue-specific genes, as compared to ubiquitous genes. Our results also indicate that negative regulation of constitutively active splicing sites can be a prevalent mode for generation of splicing variants, and that alternative splicing is generally not conserved between orthologous genes in human and mouse. Here, we discuss the implications of our findings for stem cell biology, and present possible approaches toward genome-wide identification and characterization of splice variants.
- 12 January 2006
- Published by Taylor & Francis in Cell Cycle
- Vol. 5 (4) , 347-351
Alternative Splicing Increases Complexity of Stem Cell Transcriptome
Development of highly anticipated stem cell-based therapies requires a detailed understanding of mechanisms regulating biological properties of these cells. Comprehensive identification of all biological molecules produced in stem cells is an important step toward this goal. During the past several years, microarray studies have essentially identified genes that are transcriptionally activated in various embryonic and adult stem cell populations. However, the extent of post-transcriptional modifications within the stem cell transcriptome remained undetermined. Recently, we presented evidence that thousands of genes expressed in hematopoietic and embryonic stem cells undergo alternative splicing. Using combined computational and experimental analyses, we found that the frequency of alternative splicing is especially high in tissue-specific genes, as compared to ubiquitous genes. Our results also indicate that negative regulation of constitutively active splicing sites can be a prevalent mode for generation of splicing variants, and that alternative splicing is generally not conserved between orthologous genes in human and mouse. Here, we discuss the implications of our findings for stem cell biology, and present possible approaches toward genome-wide identification and characterization of splice variants.
- 23 September 2005
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (40) , 14290-14295
Diversification of stem cell molecular repertoire by alternative splicing
Complete information regarding transcriptional and posttranscriptional gene regulation in stem cells is necessary to understand the regulation of self-renewal and differentiation. Alternative splicing is a prevalent mode of posttranscriptional regulation, and occurs in approximately one half of all mammalian genes. The frequency and functional impact of alternative splicing in stem cells are yet to be determined. In this study we combine computational and experimental methods to identify splice variants in embryonic and hematopoietic stem cells on a genome-wide scale. Using EST collections derived from stem cells, we detect alternative splicing in >1,000 genes. Systematic RT-PCR and sequencing studies show confirmation of computational predictions at a level of 80%. We find that alternative splicing can modify multiple components of signaling pathways important for stem cell function. We also analyze the distribution of splice variants across different classes of genes. We find that tissue-specific genes have a higher tendency to undergo alternative splicing than ubiquitously expressed genes. Furthermore, the patterns of alternative splicing are only weakly conserved between orthologous genes in human and mouse. Our studies reveal extensive modification of the stem cell molecular repertoire by alternative splicing and provide insights into its overall role as a mechanism of generating genomic diversity.
- 23 September 2005
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (40) , 14290-14295
Diversification of stem cell molecular repertoire by alternative splicing
Complete information regarding transcriptional and posttranscriptional gene regulation in stem cells is necessary to understand the regulation of self-renewal and differentiation. Alternative splicing is a prevalent mode of posttranscriptional regulation, and occurs in approximately one half of all mammalian genes. The frequency and functional impact of alternative splicing in stem cells are yet to be determined. In this study we combine computational and experimental methods to identify splice variants in embryonic and hematopoietic stem cells on a genome-wide scale. Using EST collections derived from stem cells, we detect alternative splicing in >1,000 genes. Systematic RT-PCR and sequencing studies show confirmation of computational predictions at a level of 80%. We find that alternative splicing can modify multiple components of signaling pathways important for stem cell function. We also analyze the distribution of splice variants across different classes of genes. We find that tissue-specific genes have a higher tendency to undergo alternative splicing than ubiquitously expressed genes. Furthermore, the patterns of alternative splicing are only weakly conserved between orthologous genes in human and mouse. Our studies reveal extensive modification of the stem cell molecular repertoire by alternative splicing and provide insights into its overall role as a mechanism of generating genomic diversity.
- Open Access
- 1 July 2005
- Published by Springer Nature in Nature Medicine
- Vol. 11 (7) , 721
Stem cell 'SLAMalot'
- 1 July 2005
- Published by Springer Nature in Nature Medicine
- Vol. 11 (7) , 721
Open AccessStem cell 'SLAMalot'
- 1 June 2005
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1044 (1) , 132-138
Stem Cell Biology: A View toward the Future
In this essay I have attempted to provide clues relating to novel research avenues that are likely to have a broad impact on the field of stem cell biology. The specific examples, drawn from other areas, are meant to be instructive and are representative of many more similar efforts. I have suggested that the new areas of systems and synthetic biology may provide a truly deep level of understanding for many aspects of how stem cells make fate choices. Successful application of new avenues will require an integrative approach that combines experimental and computational techniques.
- 1 June 2005
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1044 (1) , 132-138
Stem Cell Biology: A View toward the Future
In this essay I have attempted to provide clues relating to novel research avenues that are likely to have a broad impact on the field of stem cell biology. The specific examples, drawn from other areas, are meant to be instructive and are representative of many more similar efforts. I have suggested that the new areas of systems and synthetic biology may provide a truly deep level of understanding for many aspects of how stem cells make fate choices. Successful application of new avenues will require an integrative approach that combines experimental and computational techniques.
- 1 August 2002
- Published by Elsevier in Experimental Hematology
- Vol. 30 (8) , 848-852
A few thoughts about the plasticity of stem cells
- 1 August 2002
- Published by Elsevier in Experimental Hematology
- Vol. 30 (8) , 848-852
A few thoughts about the plasticity of stem cells
- 1 May 2002
- Published by Springer Nature in Nature Biotechnology
- Vol. 20 (5) , 425
Rethinking somatic stem cell plasticity
- 1 May 2002
- Published by Springer Nature in Nature Biotechnology
- Vol. 20 (5) , 425
Rethinking somatic stem cell plasticity
- 1 January 2001
- Published by Springer Nature in Nature Immunology
- Vol. 2 (1) , 11-12
The return of clonal marking sheds new light on human hematopoietic stem cells
- 1 January 2001
- Published by Springer Nature in Nature Immunology
- Vol. 2 (1) , 11-12
The return of clonal marking sheds new light on human hematopoietic stem cells